Table of Contents
I. Request for Information (RFI): Input into the Deliberations of the Advisory Committee to the NIH Director Working Group on the Future Biomedical Research Workforce
(NOT-OD-11-106) National Institutes of Health
II. Online Registration Open and Full Agenda Now Online: NIDA Mini-Convention at the Society for Neuroscience https://seiservices.com/nida/frontiers2011/
III. 5th Annual Julius Axelrod Symposium
IV. Neuroscience Information Framework (NIF) Turns 100
V. NEW NIH Blueprint RFI on neuroimage data-sharing http://grants.nih.gov/grants/guide/notice-files/NOT-DA-11-021.html
VI. The FOAs for the FY12 NIDA Avant-Garde Program for HIV/AIDS Research are available at http://www.drugabuse.gov/about/organization/arp/AVGP.htm
VII. Areas of high programmatic interest for the Genetics and Molecular Neurobiology Research Branch, GMNRB (NIDA).
VIII. Funding Opportunities at NIDA, please see: http://www.nida.nih.gov/funding/
I. Request for Information (RFI): Input into the Deliberations of the Advisory Committee to the NIH Director Working Group on the Future Biomedical Research Workforce
(NOT-OD-11-106) National Institutes of Health
II. Online Registration Open and Full Agenda Now Online: NIDA Mini-Convention at the Society for Neuroscience
National Institute on Drug Abuse Frontiers in Addiction Research Mini-Convention
Friday November 11, 2011
The Ronald Reagan Building and International Trade Center
Washington, DC
Seating is limited. Please register online: https://seiservices.com/nida/frontiers2011/
The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session for early career investigators. The agenda this year includes:
8:00 – 8:15 Welcome: NIDA Director
8:15 – 9:35 Autism, Addiction, and MeCP2
9:35-10:10 Jacob P. Waletzky Memorial Lecture
10:30-12:15 Synapse Organization and Plasticity in Drug Addiction
12:15- 2:15 Early Career Investigators Poster Session
2:15-4:10 Using Optogenetic Tools to Shed Light on the Neural Mechanisms of Addiction
4:20-5:40 Neurobiology of Behavioral and Emotional Regulation/Dysregulation
III. 5th Annual Julius Axelrod Symposium
NIDA, NIMH, and NINDS are soliciting poster presentations from academia, pharmaceutical and biotech companies, and government agencies aimed at the discovery of novel drug targets, ligands, and/or new methods that can be applied to the development of medications for neurological and psychiatric disorders. Preference for travel awards will be given to post-doctoral fellows and NIH Early Stage Investigators.
The National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the National Institute of Neurological Disorders and Stroke (NINDS) are co-sponsoring the 5th Annual Julius Axelrod Symposium, which celebrates the career of Dr. Julius Axelrod, one of the founders of modern neuropharmacology. This special event, to be held on Sunday, November 13, 2011 from 6:30pm -9:30pm at the Grand Hyatt Washington, 1000 H St NW, Washington DC, will feature a commemoration of Dr. Axelrod's achievements and a lecture by this year’s Julius Axelrod Prize winner. The Julius Axelrod Prize is awarded by the Society for Neuroscience (SfN) and endowed by the Eli Lilly Foundation. A poster session and reception will immediately follow the Julius Axelrod Prize winner’s lecture.
NIMH, NINDS, and NIDA are now soliciting applications for travel award poster presentations for this symposium. In the spirit of Dr. Axelrod’s research legacy, the Institutes are seeking applicants from academia, pharmaceutical and biotech companies, and government agencies whose research is aimed at the discovery of novel drug targets, ligands, and/or new methods that can be applied to the development of medications for neurological and psychiatric disorders of interest to NIMH, NINDS, and NIDA. A $750 travel award will be given to each of the 24 poster presenters selected for this session. In recognition of Dr. Axelrod’s support for the next generation of researchers, preference for travel awards will be given to post-doctoral fellows and NIH Early Stage Investigators. Abstracts accepted for the 2011 SfN Meeting may be submitted for this satellite event. Please see the attached application form for details on how to apply. Application forms may also be accessed at the event website (http://axelrod.dgimeetings.com/Poster-Information.aspx). Completed applications must be received via email (to Axelrod@mail.nih.gov) by Friday September 2, 2011, 5:00 PM (EDT) to be considered for this event. All applicants will be notified of the status of their submission by Friday, October 7, 2011.
III. Neuroscience Information Framework (NIF) Turns 100
The Neuroscience Information Framework (NIF; http://neuinfo.org) has recently federated its 100th data resource. NIF provides access to the largest searchable collection of neuroscience data and to the largest catalog of biomedical resources available. Researchers can access this data via a semantically-enhanced portal and unified framework that expose the contents of more than 108 federated databases (more than 320 million data records), the published literature (PubMed and full text indexing of open access literature from PubMed Central) and deep or “hidden” web resources, allowing users to discover content that is normally hidden from traditional search engines. NIF continually adds new information sources in response to community demand. Our latest additions include posters, videos, blogs and podcasts.
IV. NEW NIH Blueprint RFI on neuroimage data-sharing
Earlier this year, NIDA released NOT-DA-11-008, a focused RFI regarding the potential for an “addictome” repository of brain connectivity data from drug users or abusers. The enthusiastic response to that RFI has prompted the NIH Blueprint to look more broadly at the expansion of standardization of collection/data elements and sharing of NIH-funded brain images for pooling and secondary analyses that holds potential to inform about MANY brain disorders besides addiction.
As part of this initiative, a workgroup was commissioned by the Blueprint to explore the potential for expanding and facilitating brain image data sharing and standardization. A key part of this effort is to collect investigator feedback on issues regarding data-sharing and standardization of techniques, image acquisition, or data elements. The RFI for this is now live, and was just published on Friday: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-11-021.html
Responses are due October 14, 2011. NIH neuroimaging grantees are encouraged to respond.
P.S. Note that responses already submitted under the previous addictome/repository RFI will be included and appended to this new RFI- so no need to re-send if you have nothing new to add.
VI. The FOAs for the FY12 NIDA Avant-Garde Program for HIV/AIDS Research are available at http://www.drugabuse.gov/about/organization/arp/AVGP.htm
The HIV/AIDS Avant-Garde is in its fifth year, but this is the first year that applications from foreign institutions will be accepted. Awards (five years at $500K direct costs/year) support high-risk, potentially transformative research that opens new areas of HIV/AIDS research and/or may lead to new avenues for treatment and prevention of HIV/AIDS among drug users. The receipt date for the X02 pre-application is November 30, 2011.
VII. Areas of high programmatic interest for the Genetics and Molecular Neurobiology Research Branch, GMNRB (NIDA).
If you plan to submit a grant application in any of these areas for the upcoming October 5 deadline, please contact: Jonathan D. Pollock, Ph.D., Chief, GMNRB, jpollock@mail.nih.gov, 301-435-1309. This is NOT an RFA.
· Identification of rare variants in humans associated with substance abuse phenotypes. Please reference PA-11-026
· Basic functional genomic research aimed at: 1) elucidating the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction and 2) validating phenotypic differences relevant to addictive processes and biobehavioral changes. Please reference PA-11-033 (R01), PA-11-034 (R21), PA-11-035 (R03)
· Research investigating the regulatory roles of small and long non-coding RNAs in the nervous system as they relate to addictive processes. Please reference PA-11-033 (R01), PA-11-034 (R21), PA-11-035 (R03)
· Research investigating molecular mechanisms of HIV latency as it relates to addictive processes. Please reference PA-11-033 (R01), PA-11-034 (R21), PA-11-035 (R03)
· Research on genetic modifers of knockouts and transgenics that alter responses to drugs of abuse using recombinant inbred mice, collaborative cross mice, diversity outcross mice, or other approaches. Please reference PA-11-033 (R01), PA-11-034 (R21), PA-11-035 (R03)
· Investigations on the genetics analysis of behaviors associated with addiction in rats. Please reference PA-11-033 (R01), PA-11-034 (R21), PA-11-035 (R03).
· Identification of gene variants associated with cue reactivity (sign trackers vs. goal trackers) Please reference PA-11-033 (R01), PA-11-034 (R21), PA-11-035 (R03).
· Molecular and cellular analysis of adolescent brain development. Please reference PA-11-027
· Application and development of nanotechnologies for delivering nucleic acid to specific targets in the brain to treat substance abuse. Please reference PA-11-148 and PA-11-149
VIII. Funding Opportunities at NIDA, please see: http://www.nida.nih.gov/funding/
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services
TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email
- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
